Log in
(Ad)
In early 2019 President Trump warned this company's biggest customers to "step up their 5G efforts." A few months later, he banned their biggest competitor from doing business in the U.S. Now, this $5 stock could turn a $10,000 stake into $234,770 this year. But timing is critical. A single mention on the evening news and this opportunity could get away from you.

TSE:EXE.UN - Extendicare Stock Price, Forecast & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume243,008 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Extendicare Inc. (Extendicare) is a provider of post-acute and long-term senior care services. The Company offering post-acute, rehabilitative therapies and long-term care through its network of owned and operated senior care centers that include nursing centers in the United States and nursing centers in Canada. The Company operates in two segments: United States operations and Canadian operations. The Company is operating over 245 senior care centers with capacity for approximately 26,828 residents. In the United States, Extendicare's indirect wholly owned subsidiary, Extendicare Health Services, Inc., (EHSI) operates over 158 senior care facilities in the United States with approximately 15,400 beds. EHSI offers a continuum of health care services, including nursing care, assisted living and related medical specialty services, such as subacute care and rehabilitative therapy on an inpatient and outpatient basis.

Industry, Sector and Symbol

Stock Exchange TSE
Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolTSE:EXE.UN
Previous Symbol
CUSIPN/A
CIKN/A
Webhttp://www.extendicare.com/
Phone+1-905-4704000

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive EXE.UN News and Ratings via Email

Sign-up to receive the latest news and ratings for EXE.UN and its competitors with MarketBeat's FREE daily newsletter.

TSX:EXE.UN Rates by TradingView

(Ad)


Join a small community of investors looking for the next big winner. Every Sunday reveals 3 compelling stocks that should be on your radar for the week ahead. Sign up here to see what stocks have made it to our watchlist this week.

Extendicare (TSE:EXE.UN) Frequently Asked Questions

What is Extendicare's stock symbol?

Extendicare trades on the Toronto Stock Exchange (TSX) under the ticker symbol "EXE.UN."

What price target have analysts set for EXE.UN?

2 analysts have issued 1 year price targets for Extendicare's shares. Their forecasts range from C$9.00 to C$9.50. On average, they anticipate Extendicare's stock price to reach C$9.25 in the next twelve months. View Analyst Price Targets for Extendicare.

What is the consensus analysts' recommendation for Extendicare?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Extendicare in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Extendicare.

Has Extendicare been receiving favorable news coverage?

Media coverage about EXE.UN stock has been trending positive on Monday, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Extendicare earned a daily sentiment score of 3.0 on InfoTrie's scale. They also assigned media headlines about the health services provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Extendicare.

What other stocks do shareholders of Extendicare own?

Who are Extendicare's key executives?

Extendicare's management team includes the folowing people:
  • Alan D. Torrie, Independent Chairman of the Board (Age 66)
  • Timothy L. Lukenda, President, Chief Executive Officer, Director (Age 52)
  • Elaine E. Everson CPA, Chief Financial Officer, Vice President
  • Deborah C. Bakti, Vice President, Human Resources, of ECI
  • Michael A. Harris, Vice President, LTC Operations of ECI
  • Jillian E. Fountain, Corporate Secretary
  • Michael Guerriere, Director
  • Benjamin J. Hutzel, Director (Age 75)
  • Aladin W. Mawani, Director (Age 65)
  • Margery O. Cunningham, Independent Director (Age 57)

How do I buy shares of Extendicare?

Shares of EXE.UN and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Extendicare's official website?

The official website for Extendicare is http://www.extendicare.com/.

How can I contact Extendicare?

Extendicare's mailing address is 3000 Steeles Ave E Suite 103, MARKHAM, ON L3R 4T9, Canada. The health services provider can be reached via phone at +1-905-4704000.


MarketBeat Community Rating for Extendicare (TSE EXE.UN)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  70 (Vote Outperform)
Underperform Votes:  99 (Vote Underperform)
Total Votes:  169
MarketBeat's community ratings are surveys of what our community members think about Extendicare and other stocks. Vote "Outperform" if you believe EXE.UN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EXE.UN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/20/2020 by MarketBeat.com Staff

Featured Article: New Google Finance Tool and Screening Stocks
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel